One Peak Makes 6x Return on Sale of Leading AI-Driven Legal Operations Platform Brightflag to Wolters Kluwer
One Peak, a leading specialist growth equity investor, announces that it has entered into a definitive agreement to sell its interest in Shine Analytics Limited (“Brightflag”) to Wolters Kluwer (Euronext: WKL), a global leader in information solutions, software and services for professionals. Brightflag is the leading AI-driven legal operations platform, enabling corporate legal departments globally to drive visibility, automation and cost-control across the legal function.
One Peak made a significant minority investment in Brightflag in December 2020, backing a strong and experienced management team led by Ian Nolan and Alex Kelly, with the goal of building a category-defining leader within the large and rapidly growing enterprise legal management market. One Peak partnered closely with Brightflag to accelerate growth through international expansion and AI-led product innovation, establishing Brightflag as the leading AI-driven legal operations platform globally and growing revenues more than 5x since One Peak’s investment.
Ian Nolan, Co-Founder and CEO of Brightflag, said “We’re incredibly proud of what we have achieved over the past years and One Peak has been instrumental in helping us realize our global ambitions. The One Peak team’s deep knowledge of the legal technology sector and their growth-oriented operational expertise has been invaluable to our success and expansion.”
Alex Kelly, Co-Founder and COO of Brightflag, added “From the early days of our partnership, One Peak distinguished itself as a trusted and passionate supporter of our vision. They’ve stood by us through thick and thin, bringing not only a deep understanding of our business and product but also acting as invaluable sparring partners at every stage. We’re deeply thankful for their belief in Brightflag and the collaborative spirit they brought to our journey.”
Humbert de Liedekerke Beaufort, Co-Founder and Managing Partner of One Peak, added “It has been a true privilege to partner with Ian, Alex, and the entire Brightflag team on their incredible journey. From day one, their vision, drive, and unwavering commitment to transforming legal operations set them apart. We’re proud to have played a part in their growth story and are deeply grateful for the trust, collaboration, and shared ambition that defined our partnership. We wish them continued success in this exciting new chapter.”
The transaction is subject to customary closing conditions and is expected to complete in June 2025. Brightflag and its shareholders were advised by William Blair, Proskauer Rose and Maples.
About One Peak
One Peak is a leading specialist growth equity firm that invests in technology companies in the scale-up phase. One Peak provides growth capital, operating expertise, and access to its extensive network to exceptional entrepreneurs, with a view to help transform innovative and rapidly growing businesses into lasting, category-defining leaders. One Peak’s investments include Akur8, Ardoq, Cymulate, Deepki, Docplanner, Iplicit, Keepit, Lucca, Neo4j, PandaDoc, Spryker, and many others. To learn more, visit www.onepeak.tech.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250529239750/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA’s Differentiated Profile with or without Venetoclax in Frontline CLL at ASCO 202531.5.2025 14:00:00 CEST | Press release
BRUKINSA plus venetoclax demonstrated high response rates and a favorable safety profile across CLL patient types in SEQUOIA Arm D, including those with high-risk del(17p) mutational statusAt 5-year follow-up of SEQUOIA Arm C, BRUKINSA monotherapy showed sustained OS and PFS benefit in hard-to-treat del(17p) CLL patients versus historical data BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today will present new data from the Arm C and D cohorts of the pivotal, global Phase 3 SEQUOIA trial of BRUKINSA® (zanubrutinib). The findings underscore the strong and consistent efficacy of BRUKINSA across CLL patient types, including high-risk mutation status. These data will be presented in two rapid oral presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL. Data from the Arm D of SEQUOIA demonstrate that treatment with BRUKINSA plus venetoclax has the potential to drive progression-free survival and overall dee
Andersen Consulting tilføjer Stratence Partners30.5.2025 16:07:00 CEST | Pressemeddelelse
Andersen Consulting udvider sin platform med en samarbejdsaftale med Stratence Partners, der er et konsulentfirma med base i Storbritannien, som hjælper globale virksomheder med at øge markedsandele og forbedre rentabiliteten gennem deres ekspertise inden for prisfastsættelse, strategisk optimering, kommerciel effektivitet og digital transformation. Stratence Partners har en resultatorienteret tilgang og er forpligtet på bæredygtig forandring, hvorved de hjælper deres kunder gennem en unik kombination af konsulentbistand, midlertidige ledelsesindsater og oplæringskurser samt deres egne metoder og løsninger inden for datastyring, datavidenskab (AI), værktøjer og systemer. "Samarbejdet med Andersen Consulting er et spændende skridt for vores firma," sagde Fernando Ventureira, administrerende direktør for Stratence Partners. "I vores arbejde med hos ledere over hele verden har vi erfaret, at deres behov rækker ud over strategisk prisfastsættelse og driftsoptimering. Vores kunder værdsætte
You Up? Grindr’s “Right Now” Goes Global30.5.2025 15:00:00 CEST | Press release
More places, more people – Grindr’s real-time hookup feature makes connecting faster than ever Grindr, the Global Gayborhood in Your Pocket™ with more than 14.6M average monthly active users, today announced the global launch of Right Now, their newest intent-based feature designed to instantly connect people looking for immediate encounters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250530651954/en/ Grindr's Right Now feature. Right Now is a real-time feed—separate from the app’s main grid that displays profiles—where Grindr users can post text and share photos displayed for one hour, letting other like-minded users know exactly what they’re looking for. “Right Now empowers our users to find exactly what they want, when they want it – without the guesswork,” said AJ Balance, Chief Product Officer at Grindr. “We built this intention-based feature based on feedback from our community so they can connect with like-minded
CAR T Vision Coalition Launches with Ambitious Goal to Double Patients Treated with the Curative Potential of CAR T-cell Therapy by 203030.5.2025 14:00:00 CEST | Press release
Only approximately 2 out of 10 people in the US and 3 out of 10 people in Europe with certain rare, advanced blood cancers receive access to CAR T-cell therapy1,2,3New roadmap report aims to inspire collective action of stakeholder groups and invites additional CAR T-cell therapy leaders to join the coalition Today an international coalition announces the launch of CAR T Vision to unite stakeholders around the shared ambition that every eligible patient should have the opportunity for cure with CAR T-cell therapy. By 2030, the aim is to double the proportion of eligible patients treated with CAR T-cell therapy. As outlined in the new roadmap report, the coalition will work to address access challenges and drive meaningful change in the CAR T-cell therapy healthcare ecosystem with a focus on three critical priorities: increasing awareness and understanding of CAR T-cell therapy; expanding resources and capacity to deliver CAR T-cell therapy; and developing sustainable and innovative fin
Indian Educationist Dr. Achyuta Samanta Recognised With Research Institute in His Name at CUNY, USA30.5.2025 11:17:00 CEST | Press release
In a noteworthy development underscoring growing academic collaboration between India and the United States, the City University of New York (CUNY) has launched a dedicated research platform—the Achyuta Samanta India Initiative of the CUNY CREST Institute (ASIICCI). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529012005/en/ Dr. Milton Santiago, President of Bronx Community College, and Dr. Achyuta Samanta, Founder of KIIT & KISS, jointly inaugurate the Achyuta Samanta India Initiative of CUNY CREST Institute (ASIICCI) with a ribbon-cutting ceremony in New York. Named after Dr. Achyuta Samanta, a noted Indian educationist and social worker, the initiative focuses on academic research in Indian social and educational sectors, with a particular lens on Odisha. This marks one of the rare instances of a living Indian being honoured with such a naming in an American public university system. Dr. Samanta, who hails from Odisha
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom